ACTRN12620000006943
Completed
未知
A prospective, observational study to assess the dose of enteral protein delivered to critically ill adults as standard practice across intensive care units in Australia and New Zealand.
Intensive Care Research, Royal Adelaide Hospital.0 sites119 target enrollmentJanuary 8, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Critical Illness
- Sponsor
- Intensive Care Research, Royal Adelaide Hospital.
- Enrollment
- 119
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Aged 18 years or older.
- •2\. Receiving invasive mechanical ventilation.
- •3\. About to commence enteral nutrition (EN) or EN commenced within the preceding 12 hours.
Exclusion Criteria
- •1\. Expected to be receiving oral nutrition within 24 hours of inclusion.
- •2\. Have received EN or parenteral nutrition (PN) for \>12 hours in the ICU admission.
- •3\. Death is deemed to be imminent or inevitable during this admission and either the attending doctor, patient or substitute decision maker is not committed to active treatment
- •4\. The patient has an underlying disease that makes survival to 90 days unlikely
- •5\. The patient has a condition in which the treating clinician believes that administration of a very large or small amount of protein (e.g. large burn injury or urea cycle disorder respectively) is indicated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
A study to analyze the drug prescribing pattern with their side effect profile and effect of such treatment on Quality of Life among patients of acne vulgaris disease.Health Condition 1: L700- Acne vulgarisCTRI/2024/05/066802Pramod Kumar
Not yet recruiting
Not Applicable
Comparing diagnostic accuracy of two different ultrasound guided methods to confirm the position of endotracheal tube in patients undergoing elective surgeryHealth Condition 1: -CTRI/2024/03/064852Dr Neha Gupta
Recruiting
Phase 3
Dabigatran and Deep Venous ThrombosisCTRI/2023/05/052825Kasturba Medical College, Manipal
Completed
Not Applicable
A prospective observational study to evaluate direct acting antivirals combination therapy for chronic hepatis C.chronic hepatitis CJPRN-UMIN000015501Yokohama City University Medical Center1,000
Recruiting
Not Applicable
An observational, prospective study to assess the efficacy and safety of Adalloce in patients with Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS)Diseases of the musculoskeletal system and connective tissueKCT0009141Yuhan1,000